je.st
news
Amri Ceo D'Ambra plans to retire at year's end
2013-09-09 16:12:12| Biotech - Topix.net
Albany Molecular Research Inc. said Monday that president and CEO Thomas E. D'Ambra plans to retire at the end of the year, and the drug development company named non-executive board Chairman William S. Marth to replace him.
Tags: years
end
plans
ceo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||